• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prev Med Rep . SARS-CoV-2 antibodies in employees working in non-medical contact-intensive professions in the Netherlands: baseline data from the pr

tetano

Editor, Senior Moderator
Prev Med Rep


. 2021 Oct 8;101594.
doi: 10.1016/j.pmedr.2021.101594. Online ahead of print.
SARS-CoV-2 antibodies in employees working in non-medical contact-intensive professions in the Netherlands: baseline data from the prospective COco-study


Dymphie Mioch[SUP] 1 [/SUP], Sandra Kuiper[SUP] 1 [/SUP], Wouter van den Bijllaardt[SUP] 2 [/SUP], Cornelia H M van Jaarsveld[SUP] 3 [/SUP], Jan Kluytmans[SUP] 2 4 [/SUP], Esther Lodder[SUP] 1 [/SUP], Michel D Wissing[SUP] 1 [/SUP]



Affiliations

Abstract

COVID-19 has made a global impact since early 2020, requiring characterization of the SARS-CoV-2 virus, including transmission risk. The COco-study aims to evaluate the risk for COVID-19 infections in two non-medical contact-intensive professions. COco is a prospective cohort study evaluating SARS-CoV-2 antibodies in hairdressers and hospitality personnel in the province of North-Brabant in the Netherlands, using a total antibody enzyme-linked immunosorbent assay. Baseline data from June/July 2020 were analyzed. Participants filled out a questionnaire, providing information on demographics, health, work situation, and risk factors for COVID-19. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using logistic regression. In June/July 2020, 497 participants were enrolled: 236 hairdressers, 259 hospitality employees, and two participants worked in both industries. Hospitality staff was more frequently seropositive than hairdressers (14.2% versus 8.0%, respectively; OR 1.9, 95% CI 1.1-3.4). Furthermore, a high education level (OR 3.0, 95% CI: 1.7-5.6) and increased alcohol use (OR, 7 glasses per week increment: 1.3, 95% CI: 1.1-1.5) were associated with seropositivity. Of the 56 seropositive participants, 18 (32%) had not experienced any COVID-19 symptoms. The symptoms anosmia/ageusia differed most evidently between seropositive and seronegative participants (53.6% versus 5.7%, respectively; P<0.001 (chi-squared test)). In conclusion, four months after the first identified COVID-19 patient in the Netherlands, employees in the hospitality industry had significantly more frequently detectable SARS-CoV-2 antibodies than hairdressers.

Keywords: COVID-19; COVID-19 Serological Testing; Hairdressers; Hospitality industry; Non-medical contact-intensive profession; SARS-CoV-2; Seroepidemiologic Studies; coronavirus.
 
Back
Top Bottom